- Minimum 12 weeks
- Expert groups in UCL - e.g. Cancer Institute, Royal Free Hospital, MRC Laboratory for Molecular Biology, Medicine, etc.
- External Companies and Institutes - e.g GSK, European Bioinformatics Institute, Cresset, etc.
| Screening, Biology, Cell Biology and Biochemistry|
|Optimization of small molecule drug inhibition of a kinase targets for therapy of Polycystic Kidney Disease|
|Towards novel antibiotics: small molecule inhibitors of the serine/threonine protein kinases of Gram positive bacterial pathogens|
|Probing host-HIV interactions using small molecule inhibitors|
|Exploration of a new scaffold as a potential new class of a kinase inhibitor|
|Modified analogues of an established scaffold with potential for the treatment of neurodegenerative conditions |
|Computational, Cheminformatics, Bioinformatics, and computer-based literature projects|
|Drug repositioning using internal technology|
|Fragment-based design of peptidomimetic drugs |
|Natural hormones and neurotransmitters as drug leads|
|Structural and Molecular Biology|
|Crystal structure determination of protein-ligand complexes|
|Cloning and NMR study of Drug protein target|
|PK/ADME, Assay development|
|Development of PK/ADME assay for a Cancer project||
Duration: 1 year full time or 2-5 years for flexible distance learning.
Distance learning students click here for more information.
Start: September 2013
Entry requirements: Minimum of second-class Honours degree.
Click here for more information on entry requirements and term dates.
Course Credit value: UK 180/ECTS 90
Job prospects include: Biotech, Pharma, National research laboratories, NHS agencies, Medicinal Chemist, Biologist, Structural Biologist, Cheminformatian, Bioinformatian, Molecular Modeler, Information Specialist, Patent/ IP/ Knowledge Analyst.